JPS63219378A - Activated low-temperature protease - Google Patents
Activated low-temperature proteaseInfo
- Publication number
- JPS63219378A JPS63219378A JP5387587A JP5387587A JPS63219378A JP S63219378 A JPS63219378 A JP S63219378A JP 5387587 A JP5387587 A JP 5387587A JP 5387587 A JP5387587 A JP 5387587A JP S63219378 A JPS63219378 A JP S63219378A
- Authority
- JP
- Japan
- Prior art keywords
- protease
- low
- temperature
- activity
- krill
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091005804 Peptidases Proteins 0.000 title claims abstract description 51
- 239000004365 Protease Substances 0.000 title claims abstract description 46
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title claims abstract 12
- 102000035195 Peptidases Human genes 0.000 claims abstract description 39
- 230000000694 effects Effects 0.000 claims abstract description 36
- 241000239366 Euphausiacea Species 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 10
- 239000004094 surface-active agent Substances 0.000 claims abstract description 9
- 239000011780 sodium chloride Substances 0.000 claims abstract description 5
- 101710118538 Protease Proteins 0.000 claims abstract description 4
- 102000018389 Exopeptidases Human genes 0.000 claims abstract description 3
- 108010091443 Exopeptidases Proteins 0.000 claims abstract description 3
- 239000006228 supernatant Substances 0.000 abstract description 7
- 210000002808 connective tissue Anatomy 0.000 abstract description 4
- 230000002255 enzymatic effect Effects 0.000 abstract description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 239000007853 buffer solution Substances 0.000 abstract 1
- 238000002523 gelfiltration Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 235000019419 proteases Nutrition 0.000 description 30
- 102000004190 Enzymes Human genes 0.000 description 19
- 108090000790 Enzymes Proteins 0.000 description 19
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 14
- 239000000758 substrate Substances 0.000 description 11
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 10
- 229940098773 bovine serum albumin Drugs 0.000 description 10
- 102000004142 Trypsin Human genes 0.000 description 8
- 108090000631 Trypsin Proteins 0.000 description 8
- 239000012588 trypsin Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 230000000593 degrading effect Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- -1 propatool Chemical compound 0.000 description 3
- 235000019833 protease Nutrition 0.000 description 3
- 108010067770 Endopeptidase K Proteins 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- DEOKFPFLXFNAON-UHFFFAOYSA-N N-α-Benzoyl-DL-arginine 4-nitroanilide hydrochloride Chemical compound Cl.C=1C=C([N+]([O-])=O)C=CC=1NC(=O)C(CCCN=C(N)N)NC(=O)C1=CC=CC=C1 DEOKFPFLXFNAON-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 210000002196 fr. b Anatomy 0.000 description 2
- 210000003918 fraction a Anatomy 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- GKQHIYSTBXDYNQ-UHFFFAOYSA-M 1-dodecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+]1=CC=CC=C1 GKQHIYSTBXDYNQ-UHFFFAOYSA-M 0.000 description 1
- HKNNAYPWWDWHFR-UHFFFAOYSA-N 1-sulfanylbutan-1-ol Chemical compound CCCC(O)S HKNNAYPWWDWHFR-UHFFFAOYSA-N 0.000 description 1
- AEUVIXACNOXTBX-UHFFFAOYSA-N 1-sulfanylpropan-1-ol Chemical compound CCC(O)S AEUVIXACNOXTBX-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283070 Equus zebra Species 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 101710180313 Protease 3 Proteins 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- VBEGHXKAFSLLGE-UHFFFAOYSA-N n-phenylnitramide Chemical compound [O-][N+](=O)NC1=CC=CC=C1 VBEGHXKAFSLLGE-UHFFFAOYSA-N 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000005371 permeation separation Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229940067741 sodium octyl sulfate Drugs 0.000 description 1
- 229960000776 sodium tetradecyl sulfate Drugs 0.000 description 1
- WFRKJMRGXGWHBM-UHFFFAOYSA-M sodium;octyl sulfate Chemical compound [Na+].CCCCCCCCOS([O-])(=O)=O WFRKJMRGXGWHBM-UHFFFAOYSA-M 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明は活性化された低温プロテアーゼに関する。[Detailed description of the invention] (Industrial application field) The present invention relates to activated low temperature proteases.
(従来の技術)
本発明者らはオキアミが捕獲後、常温(南氷洋気温)に
放置すると急速に自己消化し、蛋白質溶解を生ずること
に着目し、オキアミ中にプロテアーゼ、キチナーゼ等の
溶解酵素が存在することを予想し、オキアミから酵素を
単離することに成功し、該酵素が低温領域に至適温度領
域を有する低温プロテアーゼであることを見い出した。(Prior art) The present inventors focused on the fact that krill rapidly self-digests when left at room temperature (Southern Ocean temperature) after capture, resulting in protein dissolution. We predicted that this would happen, and succeeded in isolating the enzyme from krill, and found that the enzyme is a low-temperature protease with an optimum temperature range in the low-temperature region.
上記オキアミから得られる低温プロテアーゼは勿論優れ
た酵素活性を有するが、更に一層優れた#素活性が得ら
れることはより望ましい。The low-temperature protease obtained from krill has excellent enzymatic activity, but it is more desirable to have even better # elementary activity.
(発明が解決しようとする問題点)
本発明の目的はより一層活性化された低温プロテアーゼ
を提供することにある。(Problems to be Solved by the Invention) An object of the present invention is to provide a further activated low-temperature protease.
(問題点を解決するための手段)
本発明はオキアミより抽出された低温プロテアーゼに界
面活性剤又はアルコール類を添加してなる活性化された
低温プロテアーゼに係る。(Means for Solving the Problems) The present invention relates to an activated low-temperature protease obtained by adding a surfactant or an alcohol to a low-temperature protease extracted from krill.
本発明で用いられる低温プロテアーゼは分子量約5万及
び約3.3万のエキソプロテアーゼ及びエンドプロテア
ーゼ活性を有する2種類のプロテアーゼを含み、約5〜
20℃の低温領域に至適温度領域を有し、NaCl耐性
を有する低温プロテアーゼである。The low-temperature protease used in the present invention includes two types of proteases having exoprotease and endoprotease activities with a molecular weight of about 50,000 and about 33,000, and has a molecular weight of about 50,000 to 33,000.
It is a low-temperature protease that has an optimum temperature range in the low-temperature range of 20°C and is resistant to NaCl.
本発明において用いられる上記プロテアーゼは、例えば
オキアミを原料として、これに適量の生理リン酸緩衝液
を加え、ホモデナイズし、粗シ濾過により結合組織を除
去後、遠心分離し、その上澄液をデルN、!過して濃縮
することにより得られる。The above-mentioned protease used in the present invention is made from krill, for example, by adding an appropriate amount of physiological phosphate buffer to it, homodenizing it, removing connective tissue by coarse filtration, centrifuging, and draining the supernatant. N,! Obtained by filtration and concentration.
即ち上記プロテアーゼは具体的には例えば次の様にして
得られる。Specifically, the above protease can be obtained, for example, as follows.
未加熱(生鮮状態)のまま、捕獲後急速凍結されたオキ
アミを凍結のまま細切して、2〜5倍量の生理リン酸緩
衝液(P B S )を加えてワーリングブレングーを
用いてホモデナイズ!7、四重が一ゼでシ戸遇して結合
組織を除去後、10.OOOxgで10〜30分遠心分
離して上澄液を採り、この上澄液を5ephacryl
S−400(スウェーデン、サルマシャ社製)を用い
て、デルシー過分離を行うことにより、プロテアーゼ活
性10倍以上に濃縮された低温プロテアーゼ酵素液が得
られる。Unheated (fresh) krill that was caught and quickly frozen was cut into small pieces while still frozen, and 2 to 5 times the volume of physiological phosphate buffer (PBS) was added to the krill using a Waring Brengu. Homodenize! 7. After removing the connective tissue by crushing the quadruple with one zebra, 10. Centrifuge for 10 to 30 minutes at OOOxg, collect the supernatant, and add 5ephacryl to this supernatant.
By performing Delcy superseparation using S-400 (manufactured by Sarmasha, Sweden), a low-temperature protease enzyme solution with a protease activity concentrated by 10 times or more is obtained.
得られたプロテアーゼの特性は次の通りである。The properties of the obtained protease are as follows.
(1)酵素活性の検出
濃縮プロテアーゼ標品(P B S溶液)を牛血清アル
ブミンを基質として反応させ、トリクロル酢酸(T C
A )沈澱を行い、上清の酸可溶性画分の増加によりプ
ロテアーゼ活性の検出を試みたが、本性では酵素活性は
認められず、ポリアクリルアミドデル電気泳動(PAG
E)にかけ牛血清アルブミンのバンドの消失により酵素
活性を調べた。その結果牛血清アルブミンバンドが完全
に消失し、低分子領域に複数のバンドが出現したことが
ら、オキアミ酵素液中にプロテアーゼ活性が確認された
。(1) Detection of enzyme activity A concentrated protease preparation (PBS solution) was reacted with bovine serum albumin as a substrate, and trichloroacetic acid (TC
A) Precipitation was performed and an attempt was made to detect protease activity by increasing the acid-soluble fraction in the supernatant, but no enzymatic activity was observed, and polyacrylamide delta electrophoresis (PAG) was performed.
E) The enzyme activity was examined by the disappearance of the bovine serum albumin band. As a result, the bovine serum albumin band completely disappeared and multiple bands appeared in the low molecular weight region, confirming protease activity in the krill enzyme solution.
本プロテアーゼは切断部位特異性が比較的高いエンドプ
ロテアーゼであり、アミノ酸10個以上のペプチド断片
を与えることを示している。このために、先のTCA法
では本酵素の活性が見出されなかった原因である。This protease is an endoprotease with relatively high cleavage site specificity, and has been shown to yield peptide fragments of 10 or more amino acids. This is the reason why the activity of this enzyme was not found in the previous TCA method.
(2)デルシ濾過による酵素の精製
オキアミホモノネートを5ephacryl S −2
00゜S−300,S−400でPBSを緩衝液として
用いて分画した結果、S−400が最適であり、1回の
デルア過分離で90%以上の活性分画を果たすことが出
来ており、この活性分画には2つの分画区が得られ、画
分A区よりは分子量約5万、画分Bがらは分子量約3.
3万のものが得られた。(2) Purification of enzyme by Delsi filtration Krill homomononate 5ephacryl S-2
As a result of fractionation using PBS as a buffer with 00゜S-300 and S-400, it was found that S-400 was the most suitable, and more than 90% of the activity could be fractionated with one Delua overseparation. Two fractions were obtained in this active fraction, with fraction A having a molecular weight of approximately 50,000, and fraction B having a molecular weight of approximately 3.
30,000 were obtained.
(3)酵素の基質特異性
本酵素はアルギニンに最も高い基質特異性を示し、リジ
ン及びロイシンに対しても活性を示したが、千ロジン及
びフェニルアラニンに対しては活性を示さなかった。こ
の基質特異性はトリプシンとMIIしており、A、B両
画分はトリプシンと同様アルギニンに対して最も高い活
性を示した。リジンに対してはトリプシンは分解初期速
度はアルギニンの50%以上であったのに対し、A、B
両画分ともかなり低い分解速度を与えた。またトリプシ
ンはロイシンに対して分解活性を示さなかったが、A、
B両画分ともに弱いロイシン分解活性を示した。(3) Substrate specificity of the enzyme This enzyme showed the highest substrate specificity for arginine, and also showed activity for lysine and leucine, but did not show activity for 1,000 rosin and phenylalanine. This substrate specificity was MII with trypsin, and both fractions A and B showed the highest activity against arginine, similar to trypsin. For lysine, the initial decomposition rate of trypsin was more than 50% that of arginine;
Both fractions gave fairly low degradation rates. Also, trypsin did not show degrading activity against leucine, but A.
Both fractions B showed weak leucine degrading activity.
(4)至適pH
種々のpHのリン酸緩衝液中でB画分を牛血清アルブミ
ン(BSA)と反応させ、PAGE法で活性を測定する
と、pH6,5〜8.0では高い活性を示した。(4) Optimal pH When the B fraction was reacted with bovine serum albumin (BSA) in phosphate buffers of various pH and the activity was measured by PAGE method, high activity was shown at pH 6.5 to 8.0. Ta.
(5)至適温度
本発明のプロテアーゼは、種々の温度で牛血清アルブミ
ンと反応させ分析した結果、第1表に示されるようにA
、B両画分共に5℃及び10 ’Cでも活性を示し、2
0℃で最大活性を示した。しがも37℃以上のより高い
温度で活性が低下したことより、低温プロテアーゼであ
り、他に例のない特異的なプロテアーゼであることが明
らかである。(5) Optimum temperature The protease of the present invention was reacted with bovine serum albumin at various temperatures and analyzed, as shown in Table 1.
Both fractions B showed activity at 5°C and 10'C, and 2
It showed maximum activity at 0°C. However, since the activity decreased at higher temperatures of 37° C. or higher, it is clear that it is a low-temperature protease and is a unique and unique protease.
即ち本プロテアーゼは、低温領域特に5〜20”Cにか
けて特異的に至適温度領域を有することを特徴とする低
温プロテアーゼである。That is, the present protease is a low-temperature protease characterized by having an optimal temperature range specifically in the low-temperature range, particularly from 5 to 20''C.
第 1 表
(6)熱安定性
本発明のプロテアーゼはA、B両画分ともに50〜70
’Cで処理すると酵素活性の部分的低下が起こり、80
°C以上では完全に失活した。Table 1 (6) Thermostability The protease of the present invention has a thermostability of 50 to 70 for both fractions A and B.
Treatment with 'C caused a partial decrease in enzyme activity, with 80
It was completely inactivated at temperatures above °C.
(7)NaC1jt性
本発明のプロテアーゼは第2表に示すように10%Na
C1存在下でも酵素活性の低下は認められなかった。(7) NaC1jt The protease of the present invention is treated with 10% NaCl as shown in Table 2.
No decrease in enzyme activity was observed even in the presence of C1.
第2表
上記のような特性を有する低温プロテアーゼに界面活性
剤又はアルコール類を添加すると、その酵素活性が一層
向上する。界面活性剤としては各種のカチオン系、アニ
オン系、/ニオン系及び両性系の界面活性剤を用いるこ
とができ、特に好適なものとしてドデシル硫酸ナトリウ
ム(S D S )、オクチル硫酸ナトリウム、テトラ
デシル硫酸ナトリウム等のアルキル硫酸テトラツム、塩
化ドデシルピリジニウムなどを挙げることができる。ま
たアルコール類としてはメタノール、エタ/−ル、プロ
パツール、ブタノール、オクタツール、デカノール、ド
デカノール、ミリスチルアルコール、セチルアルコール
、ステアリルアルコール、エイフシルアルコール、メル
カプトメタ/−ル、メルカプトエタノール(M S H
L メルカプトプロパツール、メルカプトブタノール等
を挙げることができる。界面活性剤又はアルコール類の
添加量は広い範囲から選択できるが、通常は基質濃度と
して約1〜30重量%、好ましくは約1〜15重量%、
更に好ましくは約3〜10重量%とするのが良い。添加
は公知の各種の方法に従って行うことができる。Table 2 When a surfactant or an alcohol is added to a low-temperature protease having the above characteristics, its enzymatic activity is further improved. As the surfactant, various cationic, anionic, /ionic and amphoteric surfactants can be used, and particularly preferred ones include sodium dodecyl sulfate (SDS), sodium octyl sulfate, and sodium tetradecyl sulfate. Examples include alkyl tetratum sulfates, dodecylpyridinium chloride, etc. Alcohols include methanol, ethanol, propatool, butanol, octatool, decanol, dodecanol, myristyl alcohol, cetyl alcohol, stearyl alcohol, eifyl alcohol, mercaptometh/ol, mercaptoethanol (MSH
Examples include L mercaptopropanol and mercaptobutanol. The amount of surfactant or alcohol added can be selected from a wide range, but usually the substrate concentration is about 1 to 30% by weight, preferably about 1 to 15% by weight,
More preferably, it is about 3 to 10% by weight. Addition can be carried out according to various known methods.
(実 施 例) 以下に実施例を挙げて説明する。(Example) Examples will be described below.
実施例1
未加熱(生鮮状態)のまま、捕獲後急速凍結されたオキ
アミを凍結のまま細切して、3倍量の生理リン酸緩衝液
(P B S )を加えてワーリングブレングーを用い
てホモデナイズし、四重が一層でシ濾過して結合組織を
除去後、10.OOOxgで10〜30分遠心分離して
上澄液を採り、この上澄液をS epl+acrylS
−400を用いて、デルヂ過分離を行うことにより、プ
ロテアーゼ活性10倍以上に濃縮された低温プロテアー
ゼ酵素液を得た。Example 1 Unheated (fresh state) krill that was caught and quickly frozen was cut into small pieces while still frozen, and 3 times the amount of physiological phosphate buffer (PBS) was added to the krill, which was then processed using a Waring Brengu. After homodenizing and filtering through four layers to remove connective tissue, 10. Centrifuge for 10 to 30 minutes at OOOxg, collect the supernatant, and add this supernatant to Sepl+acrylS.
-400 was used to perform Delgi permeation separation to obtain a low temperature protease enzyme solution with a protease activity concentrated 10 times or more.
得られた酵素液を用い、クシ血清アルブミン(BSA)
を基質として用い下記方法により酵素活性を測定する場
合に、SDS又はMSHを添加して測定した。Using the obtained enzyme solution, comb serum albumin (BSA)
When enzyme activity was measured by the method described below using as a substrate, SDS or MSH was added to the measurement.
(A)PAGE法
ポリアクリルアミドデル電気泳動法
(B)BAPNA法
合成基質としてN−a−ベンゾイル−DL−アルギニン
−p−ニトロアニリド(BAPNA)を用い生成するp
−ニトロアニリン量A 40%を測定する。(A) PAGE method polyacrylamide del electrophoresis method (B) BAPNA method p produced using Na-benzoyl-DL-arginine-p-nitroanilide (BAPNA) as a synthesis substrate
- Measure the amount of nitroaniline A 40%.
結果を第3表に示す。比較のため界面活性剤又はアルコ
ール類を添加しない場合、酵素としてトリプシンを使用
した場合についてら記した。尚、濃度は基質に対する終
濃度を示す(以下同様)。The results are shown in Table 3. For comparison, the case where no surfactant or alcohol was added and the case where trypsin was used as the enzyme were described. Note that the concentration indicates the final concentration of the substrate (the same applies below).
t143表
第3表に示されるように本発明のプロテアーゼはMSH
及びSDSを添加しない場合は合成基質のみ分解するが
、高濃度のMSH存在下ではBSA分解活性を示し、合
成基質の分解活性も上昇する。SDS存在下では合成基
質分解活性は失われているが、BSA分解活性は促進さ
れ、MSH添加濃度の増大に伴い活性は上昇した。トリ
プシンの場合は高濃度のMSH存在下ではかえって酵素
活性の阻害が認められることが判る。As shown in Table 3 of Table t143, the protease of the present invention is MSH
When SDS is not added, only the synthetic substrate is degraded, but in the presence of a high concentration of MSH, BSA degrading activity is exhibited and the degrading activity of the synthetic substrate also increases. In the presence of SDS, the synthetic substrate decomposition activity was lost, but the BSA decomposition activity was promoted, and the activity increased as the concentration of MSH added increased. In the case of trypsin, it can be seen that the enzyme activity is actually inhibited in the presence of a high concentration of MSH.
実施例2
本発明のプロテアーゼの画分A及び画分BのSDS存在
下での酵素活性を調べた。結果を第4表に示す。尚、比
較のためSDSを添加しない場合、トリプシン及びブロ
テイナーゼKを使用した場合についても記した。Example 2 The enzyme activity of fraction A and fraction B of the protease of the present invention in the presence of SDS was investigated. The results are shown in Table 4. For comparison, the case where SDS was not added and the case where trypsin and proteinase K were used were also described.
第 4 表
第4RよりA、B両画分とも1%以上のSDS濃度で強
いBSA分解活性を示し、ブロテイナーゼにと同様に高
いS D S It性を示したが、トリプシンは高いS
DS濃度においては活性を失った。From Table 4, Table 4R, both fractions A and B showed strong BSA degrading activity at an SDS concentration of 1% or more, and showed high SDS It properties similar to that of proteinase, but trypsin had a high SDS
It lost activity at DS concentration.
多くの酵素はSDS存在下では変性失活する。これまで
SDS中で活性を示すプロテアーゼとしてはプロテイナ
ーゼKが知られているのみであり、細菌や動物細胞の核
酸を調製する際のタンパク質の除去を目的として、遺伝
子工学分野で用いられてきた0本発明のプロテアーゼは
、プロテイナーゼにと同様に8%SDS存在下でも酵素
活性の低下が認められなかった。従って、本酵素はプロ
テイナーゼにと同様に遺伝子工学研究用試薬としての利
用が可能である。また、SDSは界面活性剤として洗剤
、ねり歯磨きなどに利用されている。Many enzymes are denatured and inactivated in the presence of SDS. Until now, proteinase K is the only known protease that shows activity in SDS, and it has been used in the field of genetic engineering for the purpose of removing proteins when preparing nucleic acids from bacteria and animal cells. Similar to proteinase, the protease of the invention showed no decrease in enzyme activity even in the presence of 8% SDS. Therefore, this enzyme can be used as a reagent for genetic engineering research in the same way as proteinase. Additionally, SDS is used as a surfactant in detergents, toothpaste, etc.
と(に洗剤においてはプロテアーゼの添加は洗浄力の向
上に大きく寄与しうるので、種々の応用開発が期待され
る。Since the addition of protease to detergents can greatly contribute to improving detergency, various applications are expected.
(以 上)
出 願 人 林兼産業株式会社
代 理 人 弁理士 1)村 巌
手続補正書
昭和62年9月10日
昭和62年特許願第53875号
2、発明の名称
活性化された低温プロテアーゼ
3、lll正をする者
事件との関係 特許出願人
林兼産業株式会社
4、代理人
〒530大阪市北区首根崎1丁目2番8号マルビル 電
話06 (365) 01フ0(8153) 弁理士
1)村 巌5、補正命令の日付
自発
6、補正の対象
明細書中「発明の詳細な説明」の項
7、補正の内容
(1)明細書第3頁第7行
「得られる。」を[得られる。又、本発明のプロテアー
ゼは微生物の遺伝子操作等によっても得ることができる
。]と訂正します。(Above) Applicant Hayashikane Sangyo Co., Ltd. Agent Patent Attorney 1) Iwao Mura Procedural Amendment September 10, 1988 Patent Application No. 53875 2, Title of Invention Activated Low Temperature Protease 3 ,Relationship with the case of a person who makes a correction Patent applicant: Hayashikane Sangyo Co., Ltd. 4, Agent: Maru Building, 1-2-8 Kunezaki, Kita-ku, Osaka 530 Telephone: 06 (365) 01F 0 (8153) Patent attorney 1 ) Iwao Mura 5, date of amendment order 6, section 7 of "Detailed Description of the Invention" in the specification subject to amendment, content of amendment (1) "Obtained" on page 3, line 7 of the specification [ can get. Furthermore, the protease of the present invention can also be obtained by genetic manipulation of microorganisms. ] Correct.
(以 上)(that's all)
Claims (2)
活性剤又はアルコール類を添加してなる活性化された低
温プロテアーゼ。(1) Activated low-temperature protease obtained by adding a surfactant or alcohol to low-temperature protease extracted from krill.
子量約5万及び約3.3万のエキソプロテアーゼ及びエ
ンドプロテアーゼ活性を有する2種類のプロテアーゼを
含み、約5〜20℃の低温領域に至適温度領域を有し、
NaCl耐性を有する低温プロテアーゼである特許請求
の範囲第1項記載の活性化された低温プロテアーゼ。(2) Low-temperature protease extracted from krill contains two types of proteases with molecular weights of approximately 50,000 and 33,000, having exoprotease and endoprotease activities, and has an optimal temperature in the low temperature range of approximately 5 to 20 degrees Celsius. has an area,
The activated low-temperature protease according to claim 1, which is a low-temperature protease having NaCl tolerance.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5387587A JPS63219378A (en) | 1987-03-09 | 1987-03-09 | Activated low-temperature protease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5387587A JPS63219378A (en) | 1987-03-09 | 1987-03-09 | Activated low-temperature protease |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63219378A true JPS63219378A (en) | 1988-09-13 |
Family
ID=12954919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5387587A Pending JPS63219378A (en) | 1987-03-09 | 1987-03-09 | Activated low-temperature protease |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63219378A (en) |
-
1987
- 1987-03-09 JP JP5387587A patent/JPS63219378A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ketnawa et al. | Enhanced recovery of alkaline protease from fish viscera by phase partitioning and its application | |
EP0112849A1 (en) | A process for the preparation of chymosin. | |
Birkedal-Hansen et al. | Cleavage of bovine skin type III collagen by proteolytic enzymes. Relative resistance of the fibrillar form. | |
CA2174231C (en) | Process for preparing an inter-alpha-trypsine inhibitor concentrate for therapeutical use, and concentrate thus obtained | |
JPS584728A (en) | Purification of alpha-1 antitrypsin | |
Starkey | The effect of human neutrophil elastase and cathepsin G on the collagen of cartilage, tendon, and cornea | |
JP5425930B2 (en) | Electrophoretic analysis method | |
EP0726311B1 (en) | Process for preparing human activated protein c | |
JPS63219378A (en) | Activated low-temperature protease | |
US5811279A (en) | Method for activating prothrombin with polyethylene glycol | |
JP5100651B2 (en) | Method for removing bisulfite by-products from enzyme compositions | |
US20050260704A1 (en) | Novel thrombolytic enzyme and a process for its preparation | |
GB1581472A (en) | Compounds of the plasminogen type processes for their production and pharmaceutical compositions containing them | |
JPH01160496A (en) | Method for selective disintegration of fused protein | |
WO2000061711A1 (en) | Composition for decomposing protein | |
Duque-Magalhaes et al. | Cytochrome c degrading activity in rat liver mitochondria | |
KR100407764B1 (en) | Method for Production of Silk Peptides | |
RU2584601C1 (en) | Method of extracting proteolytic terrilytin enzyme | |
CA2030783A1 (en) | Process for preparation of activated protein c and activated protein c obtained thereby | |
JPS63219351A (en) | Protease-compounded pickling agent for meat processing, or the like | |
JPS63219348A (en) | Fermentation product compounded with protease | |
JPS63219377A (en) | Low-temperature protease and isolation thereof | |
JPH0813271B2 (en) | Fibrinolytically active protein and method for producing the same | |
JPS63218610A (en) | Cosmetic compounded with protease | |
JP2657694B2 (en) | Chemical modification enzyme and peptide synthesis method |